Parvez, M. M. Et Al. 2022. Para-aminosalicylic acid significantly reduced tenofovir exposure in human subjects: Mismatched findings from in vitro to in vivo translational research. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY , vol.88, no.3 , 1159-1169.

Parvez, M. M., Kalkisim, S., Nguyen, P. T. T., Jung, J. A., Park, J., Ghim, J., ... Kim, E.(2022). Para-aminosalicylic acid significantly reduced tenofovir exposure in human subjects: Mismatched findings from in vitro to in vivo translational research. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY , vol.88, no.3, 1159-1169.

Parvez, Md Et Al. "Para-aminosalicylic acid significantly reduced tenofovir exposure in human subjects: Mismatched findings from in vitro to in vivo translational research," BRITISH JOURNAL OF CLINICAL PHARMACOLOGY , vol.88, no.3, 1159-1169, 2022

Parvez, Md M. Et Al. "Para-aminosalicylic acid significantly reduced tenofovir exposure in human subjects: Mismatched findings from in vitro to in vivo translational research." BRITISH JOURNAL OF CLINICAL PHARMACOLOGY , vol.88, no.3, pp.1159-1169, 2022

Parvez, M. M. Et Al. (2022) . "Para-aminosalicylic acid significantly reduced tenofovir exposure in human subjects: Mismatched findings from in vitro to in vivo translational research." BRITISH JOURNAL OF CLINICAL PHARMACOLOGY , vol.88, no.3, pp.1159-1169.

@article{article, author={Md Masud Parvez Et Al. }, title={Para-aminosalicylic acid significantly reduced tenofovir exposure in human subjects: Mismatched findings from in vitro to in vivo translational research}, journal={BRITISH JOURNAL OF CLINICAL PHARMACOLOGY}, year=2022, pages={1159-1169} }